Skip to main content
. 2024 Feb 27;29(7):102267. doi: 10.1016/j.jaccas.2024.102267

Figure 3.

Figure 3

Patient 3 Serial T-2 Weighted CMR Imaging

Comparison of serial T2-weighted cardiac magnetic resonance (CMR) images for patient 3. Before initiation of mepolizumab and after initial steroid taper (month 0), CMR imaging demonstrated diffusely elevated T2 signal throughout the myocardium. After the initiation of mepolizumab in combination with a reduced prednisone dose, CMR imaging (month 3) showed stability of elevated T2 signal in the setting of clinical symptom improvement.